Σύγκριση μεθόδων

	AcroQoL: Ερωτηματολόγιο Ποιότητας Ζωής στην Ακρομεγαλία	Ερωτηματολόγιο Ποιότητας Ζωής για το Σύνδρομο Cushing (CushQoL)
Πεδίο	Ενδοκρινολογία	Ενδοκρινολογία
Οικογένεια	Process / pipeline	Process / pipeline
Έτος προέλευσης	2006	2008
Δημιουργός	Markus Buchfelder, Dieter Weigel, Monica Droste, et al.	Sergio Webb, María D. Bernal, Juan M. Rivera-Caravaca
Τύπος	Patient self-report questionnaire	Patient self-report questionnaire
Θεμελιώδης πηγή	Buchfelder, M., Weigel, D., Droste, M., et al. (2006). The quality of life of acromegaly patients is markedly impaired: Data from the German Acromegaly Registry. Eur J Endocrinol, 150(4), 541-549.	Webb, S. M., Bernal, M. D., Rivera-Caravaca, J. M., & Córdoba-Soriano, J. G. (2008). Development and validation of CushQoL, a disease-specific quality of life questionnaire in Cushing's syndrome. J Clin Endocrinol Metab, 93(5), 1751-1759.
Εναλλακτικές ονομασίες	Acromegaly QoL, Acro-QoL	Cushing QoL, CS-QoL
Συναφείς	3	3
Σύνοψη	AcroQoL is a disease-specific 22-item quality of life questionnaire developed to assess the multidimensional burden of acromegaly, a chronic growth hormone-secreting pituitary tumor disorder. Developed by Buchfelder and colleagues in 2006, it captures physical complications (joint/bone pain, carpal tunnel syndrome, metabolic disease), appearance-related concerns (facial changes, hand/foot enlargement), and psychological/social impacts (mood, social limitation, body image). It is the primary outcome measure for assessing quality of life in acromegaly treatment trials and clinical practice.	CushQoL is a disease-specific 12-item quality of life questionnaire developed to assess the multidimensional impacts of Cushing's syndrome—a severe endocrine disorder characterized by excess cortisol production. Developed by Webb and colleagues in 2008, it captures physical symptoms (fatigue, weight gain, weakness, hirsutism), psychological manifestations (depression, anxiety, cognitive impairment), and social/occupational dysfunction unique to Cushing's syndrome. It is the standard outcome measure for assessing quality of life improvement following curative therapy.